PHOENIX, Sept. 18, 2019 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, today announced the opening of its seventh dispensary in Arizona at 2175 N 83rd Avenue in the Phoenix metro area. Curaleaf Pavilions is a newly developed, flagship dispensary with close access to the I-10 Freeway. The dispensary is in the immediate vicinity of the nationally recognized Ak-Chin Pavilion, a popular outdoor amphitheater and concert stadium hosting nearly forty events a year.
"Maricopa is the fastest-growing county in the country," said Joe Lusardi, President and Chief Executive Officer of Curaleaf.
By opening the seventh Curaleaf dispensary in Arizona, we will be able to provide this expanding population with access to our high-quality cannabis products and exceptional customer service.Joe Lusardi, President and Chief Executive Officer of Curaleaf
To celebrate, Curaleaf Pavilions will host a grand opening party on Friday, October 4th. The event will feature product specials, including BOGO (buy-one-get-one) discounts on select products, giveaways and prizes.
Earlier this year, Curaleaf agreed to acquire Phytotherapeutics Management Services, LLC. The license associated with that dispensary was applied to Curaleaf Pavilions.
The opening of Curaleaf Pavilions follows the recently completed acquisition of Glendale Greenhouse and represents the Company's third acquisition in the state of Arizona over the past four months, giving Curaleaf the second largest retail footprint in the state. Curaleaf's successful expansion in Arizona is emblematic of its aggressive expansion plans across the United States, including the completed acquisition of Eureka in California and the pending acquisitions of Acres in Nevada, Select and Grassroots.
Disclaimer: past performance is not an indicator of future performance.
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is the leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 49 dispensaries, 14 cultivation sites and 13 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand.
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!